AImtract--Using quantitative autoradiography, the cellular localization and characterization of cerebellar excitatory amino acid binding sites in normal, Purkinje cell-deficient and granuloprival (granule cell-deficient) mouse cerebella were investigated. In the molecular layer of normal mouse cerebellum, the quisqualate subtype of excitatory amino acid receptor (assayed by [3H](RS)-a-amino-3-hydroxy-5-methylisoxazole-4-propionate, quisqualate-sensitive L-[3H]glutamate, and [3H]6-cyano-7-nitroquinoxaline-2,3-dione binding) predominated. In the granule cell layer of the cerebellum, N-methyl-oaspartate-sensitive L-[3H]glutamate and [3H]glycine binding sites were predominant.
AImtract--Using quantitative autoradiography, the cellular localization and characterization of cerebellar excitatory amino acid binding sites in normal, Purkinje cell-deficient and granuloprival (granule cell-deficient) mouse cerebella were investigated. In the molecular layer of normal mouse cerebellum, the quisqualate subtype of excitatory amino acid receptor (assayed by In the molecular layer of Purkinje cell-deficient mutant mice, [JH] (RS)-~,-amino-3-hydroxy-5-methylisoxazole-4-propionate binding sites and [3H]6-cyano-7-nitro-quinoxaline-2,3-dione binding were reduced to 24% (P < 0.01) and 36% (P < 0.001) of control, respectively, while quisqualate-sensitive [3H]glutamate binding sites were reduced to 54% of control (P < 0.01). N-Methyl-I)-aspartate-sensitive [3H]glutamate and [3H]glycine binding were unchanged. In the granule cell layer of these mouse cerebella, there was no change in excitatory amino acid receptor binding.
In the molecular layer of granuloprival mouse cerebella, [3H](RS)-a-amino-3-hydroxy-5-methylisoxa. zole-4-propionate binding was increased to 205 % of control (P < 0.01), [3H]6-cyano-7-nitro-quinoxaline-2,3-dione binding was increased to 136% of control (P < 0.02), and quisqualate-sensitive [3H]glutamate binding was increased to 152% of control (P < 0.01). N-Methyl-o-aspartate-sensitive [3H]glutamate and [~H]glycine binding were unchanged. In areas of granule cell depletion N-methyl-D-aspartate-sensitive [3H]glutamate and [3H]glycine binding were reduced to 68% (P < 0.01) and 59% (P < 0.01) of control, respectively. In the granule cell layer, binding to quisqualate receptors was not significantly different from binding in controls with any of the ligands tested.
These results suggest that three different receptor assays: [3H](RS)-~-amino-3-hydroxy-5-methylisoxazole-4-propionate, quisqualate-sensitive L-[3H]glutamate, and [3H]6-cyano-7-nitro-quinoxaline-2,3-dione binding can be used to demonstrate that quisqualate receptor specific binding sites are located on Purkinje cell dendrites in the molecular layer of cerebellum, and that these binding sites apparently up-regulate in response to granule cell ablation and Purkinje cell deafferentation.
Glutamate is a major excitatory neurotransmitter in the mammalian central nervous system, s,45 Electrophysiological evidence indicates that the excitatory action of glutamate is mediated by at least three subtypes of ion channel-linked ("ionotropic") receptors named according to the agonists which preferentially excite them: N-methyl-o-aspartate (NMDA), quisqualate, and kainate. 9 In addition, a new type of glutamate receptor, a quisqualate-preferring "metabotropic" receptor, linked to inositol phospholipid metabolism has been reported. 42 The cerebellar cortex is a convenient region in which to study excitatory amino acid (EAA) receptors because the cerebellar neuronal circuitry is well understood33"3° Extensive morphological and neurochemical evidence supports a neurotransmitter function for L-glutamate at afferent mossy fiber terminals ''l°'t2 and intrinsic granule cell/parallel fiber synapses, 22' 26"4° and for L-aspartate at afferent climbing fiber-Purkinje cell synapses. 39,~ Thus, cerebellar Purkinje cells receive EAA input from both the climbing fibers and the granule cell/parallel fiber system, while the granule cells receive such input from 671 the mossy fibers. Selective mutations and cytotoxic drug treatments alter cerebellar circuitry by rendering the cerebellum deficient in specific cell types. 24 '43 The pharmacological evidence for the multiplicity of EAA receptors underscores the importance of identifying the specific EAA receptor subtypes mediating neuronal transmission in the cerebellar cortex. Previous work in our laboratory by Olson et al. 36 suggested that quisqualate-sensitive binding sites are located principally on dendrites of Purkinje cells and that they up-regulate after deafferentation. Advances in EAA research have led to the development of several new ligands specific for the ionotropic quisqualate receptor. AMPA has been described as a potent and selective agonist of the ionotropic quisqualate receptor and the compound has been radiolabeled. 2°'34 Studies using [3H]AMPA have been difficult to interpret due to the presence of both high and low affinity binding sites. 19 '33 Recently, a relatively selective antagonist, 6-cyano-7-nitro-quinoxaline-2,3-dione (CNQX), of quisqualate-or AMPA-induced responses has been developed. In binding studies CNQX has been shown to bind with a single affinity to both the high and low affinity AMPA binding sites. 35 
Animals
Homozygous recessive "nervous" mutant mice (nr/nr) which are 90% deficient in Purkinje cells were obtained from Jackson Laboratories (Bar Harbor, ME). 4~ Neurologically normal littermates (nr/+ ) served as controls. Binding experiments were performed in 42-day-old mice. Granuloprival mice were produced by injecting pups of male CD-I mice from Charles River Labs (Wilmington, MA) with methylazoxymethanol (MAM, 30 mg/kg diluted to a concentration of 10 mg/ml in 0.9% NaC1) subcutaneously within 4 h of birth. MAM is a nucleic acid alkylating agent which kills cells undergoing mitosis at the time of drug distribution. When injected on postnatal day 1, MAM causes a depletion of granule, stellate, basket, and Golgi cells while sparing Purkinje cells in the mouse cerebellum. 6:6'24'25 Binding experiments were performed in 42-day-old mice that had been treated as pups with MAM. Saline-injected littermates were used as controls.
Tissue preparation
Forty-two-day-old mice were decapitated and their brains were quickly removed. Cerebella were separated from forebrain, mounted on cryotome pedestals with Lipshaw embedding matrix, and frozen under powdered dry ice. The frozen cerebella were cut into 20/~m sections at -20°C on a Lipshaw cryostat and thaw mounted onto gelatin-coated slides. Sections were stored for less than 24 h at -20°C. To remove endogenous ligands, all sections underwent a prewash for 30 After incubation with tritiated ligands, sections were rinsed quickly three times with cold buffer and then rinsed with cold 2.50 (v/v) glutaraldehyde in acetone. The total rinse time was less than 10 s. Sections were blown dry with warm air. Dried sections were placed in X-ray cassettes with appropriate radioactive standards 37 and apposed to Amersham Hyperfilm. The film was exposed to the tissue sections for 14--21 days at 4°C and then developed, fixed, and dried. Tissue sections were then postfixed with paraformaldehyde and stained with Cresyl Violet. Individual layers of cerebellum were identified on autoradiographs by comparison with the Cresyl Violet-stained sections of the same tissue producing the film image. The optical densities of the resultant film images were determined using a computer-assisted, video-based image analysis system (Imaging Research, St Catherines ONT, Canada). Twelve to 18 readings were averaged from each area of interest in triplicate sections. The radioactivity was determined by a computer-generated polynomial regression analysis that compared film densities Mouse cerebellar excitatory amino acid receptors 673 produced by the tissue sections to those produced by the radioactive standards. All data presented were analysed densitometrically from autoradiographic images.
Data analysis
Binding to the molecular layer and granule layers of granuloprival mice was compared to that in saline-treated littermates. Similarly, binding in homozygous "nervous" mutant mice lacking Purkinje ceils was compared to neurologically normal littermates. Scatchard analysis and the resulting K a and Bm~ values were resolved by the non-linear regression program LIGAND. 32 Statistical analysis was by unpaired t-tests.
RESULTS

Histology
In normal cerebellum the granule cell layer is characterized by a very dense collection of cell nuclei. The Purkinje cell layer is a monolayer of large neurons with pale staining nuclei located between the granule cell layer and the molecular layer. The outer layer (molecular layer) has relatively few intrinsic neurons (basket and stellate cells), and the abundant neuropil consists largely of granule cell axons and Purkinje cell dendrites (Fig. 1A) . In "nervous" mutant mice (nr/nr), there was a severe depletion of Purkinje cells. The granule cell layer had a normal cell density, whereas the molecular layer was thinner than normal (Fig. IB) . In the granuloprival (MAMtreated) mice, there was a marked depletion of granule cells in a patchy distribution. The damaged granule cell layer appeared wider than normal, but had a markedly decreased density of granule cell nuclei. The molecular layer was slightly narrower than in saline-treated controls but had no increase in the number of glial cell nuclei. Purkinje cells in these animals appeared normal (Fig. 1C) .
Nervous (Purkinje cell-deficient) mice and heterozygous controls
In control (nr/+ ) mice [3H]AMPA binding sites (which label ionotropic quisqualate receptors) were 13 times as numerous in the molecular layer as they were in the granule cell layer (total Bm~ x = 36.2 vs 2.7 pmol/mg protein; Figs 2A and 3A) . In the presence of 100mM KSCN, saturation studies of [3H]AMPA binding produced curvilinear Scatchard plots which fit a two-site model better than a one-site model (P < 0.001, F-test as compared to a linear fit; Fig. 4 (Table 1) shows a reduction in the low affinity B~a~ to 24% of control (P < 0.01) and a slight but non-significant decrease in the affinity of the high affinity binding site (Fig. 3A, B) . (Table 2) .
[3H]CNQX, an ionotropic quisqualate receptor antagonist, revealed binding characteristics similar to 
Fig. 2. Autoradiographs of [3H]AMPA binding (A), [3H]CNQX binding (B), quisqualate-sensitive [3H]glutamate binding (C), and NMDA-sensitive [3H]glutamate binding (D) in control cerebellum. The three quisqualate receptor-specific ligands bind primarily in the molecular layer (M) while the NMDA-sensitive binding is primarily localized to the granule cell layer (G).
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Fig. 3. Autoradiographs of [3H]AMPA binding (A~) and [3H]glycine binding (D-F) in control cerebellum
(A, D), Purkinje cell-deficient ("nervous" mutant) cerebellum (B, E), and granuloprival (MAM-treated) cerebellum (C, F). Although separate sets of controls were used for comparison with the Purkinje cell-deficient ("nervous") mice and the granuloprival (MAM-treated) mice, as described under Experimental Procedures, only the controls used in the Purkinje cell-deficient ("nervous" mutant) experiment are shown.
[3H]AMPA ( Fig. 2A, B) . In control mice, when binding was done at 90 nM [3H]CNQX there was more binding in the molecular layer than in the granule cell layer of cerebellum (9.9 vs 1.7 pmol/mg protein) and there was a large decrease in binding in the molecular layer of"nervous" mice (9.9 vs 3.5 pmol/mg protein).
[3H]CNQX binding was reduced to 36% of control (P<0.01) in the molecular layer of "nervous" mutant mice while [3H]CNQX binding was unchanged in the granule cell layer of these mice (1.7 vs 1.5 pmol/mg protein; Table 2 ). In contrast to the quisqualate receptor ligands, there was more NMDA-sensitive [3H]glutamate binding in the granule cell layer of control (nr/+ ) mice "nervous" mice compared to heterozygote controls (Fig. 3D, E) . than in the molecular layer (0.15 vs 0.02pmol/mg protein; Fig. 2D ). "Nervous" mutant mice had unchanged levels of NMDA binding in both the granule cell layer and the molecular layer (Table 2) . In control mice [3H]glycine binding, which labels the glycine modulatory site associated with the NMDA receptor complex, 3 paralleled NMDAsensitive binding in that there was more [3H]glycine binding in the granule cell layer than in the molecular layer (1.2 vs 0.1pmol/mg protein; Fig. 3D ).
[3H]Glycine binding was not significantly changed in either the molecular layer or granule cell layer of
Granuloprival mice and saline-injected controls
In the molecular layer of granuloprival (MAMtreated) mouse cerebella, [3H]AMPA binding (measured at a single concentration of 37 nM) was increased to 205% of control (4.1 vs 2.0pmol/mg protein; P < 0.01) in regions adjacent to severe granule cell depletion (Fig. 3C) (Table 2) .
DISCUSSION
Nervous (Purkinje cell-deficient mice)
Accumulated evidence suggests that L-glutamate is the endogenous EAA neurotransmitter at the parallel fiber-Purkinje cell synapse. 2'26'27'4s Biochemical data reveal that L-glutamate is contained in parallel fibers, and that it is released in a calcium-dependent fashion. 2s,4° The parallel fiber-Purkinje cell synapse is the most numerous synapse in the molecular layer of cerebellum) ° Autoradiographic binding studies have demonstrated previously that 75% of glutamate binding in the molecular layer of normal mice is associated with binding to quisqualate-sensitive sites. 4 The correlation between the abundant parallel fiber-Purkinje cell synapses and the comparably abundant quisqualate-sensitive binding suggests that quisqualate receptors mediate glutamate responses at this synapse.
AMPA is thought to be a potent agonist at the quisqualate subclass of glutamate receptors linked to a cationic membrane channel. In agreement with previous binding studies, in the presence of thiocyanate, [3H]AMPA binding produced curvilinear Scatchard plots in the molecular layer of cerebellum which could be resolved into two binding sites. 19 ' 33 In the molecular layer of "nervous" mice lacking Purkinje cells there was a large decrease in the low affinity [3H]AMPA binding site (Table 1) but no change in the high affinity [3H]AMPA binding. In contrast, saturation analysis of [3H]AMPA binding in the granule cell layer of cerebellum produced linear Scatchard plots indicating only high affinity sites and these sites did not change in "nervous" mice. Ligand binding studies utilizing [3H]AMPA have been complicated by the presence of high and low affinity binding sites and it is not known whether the low affinity or high affinity AMPA site revealed in ligand binding studies corresponds to the physiologically active receptor. In the present study, our Scatchard analyses indicate that the low affinity site appears to be specific to the Purkinje cells and may thus be the relevant receptor there (Fig. 4) . Any remaining [3H]AMPA binding sites are probably located on the 10% of Purkinje cells unaffected by the "nervous" mutation or on remaining basket, stellate, and Golgi cells with which the parallel fibers also synapse.
Previously, it has been demonstrated that the regional correlation between levels of quisqualatesensitive [3H]glutamate binding and [3H]AMPA binding is excellent, but some differences do exist. 34 Fig. 2A, B (Fig. 2D) . ~4,36 These binding sites in the granule cell layer may be located on the granule cells themselves as they are the target of excitatory input from mossy fibers, and based on immunocytochemical data, the mossy fibers may be giutamatergic.l In Purkinje cell-deficient mutant mice, NMDA binding sites were unchanged in the molecular layer of cerebellar cortex. This evidence suggests that few, if any, NMDA binding sites are located on Purkinje cell dendrites and further strengthens the supposition that quisqualate receptors mediate excitatory transmission at the parallel fiber-Purkinje cell synapse. It is likely that binding to NMDA receptors in the molecular layer is localized to stellate cells and possibly to basket and Golgi cells: this is in agreement with electrophysiological studies in which NMDA has prominent effects on inhibitory interneurons when applied iontophoretically. 7,3s
In agreement with this, [3H]glycine binding, which presumably binds to the glycine site associated with the NMDA receptor complex, mimics the NMDA binding results (Fig. 3A) . These binding data, in conjunction with electrophysiological and neurotoxicity studies, further suggest that the NMDA receptor complex is not localized to Purkinje cells. 7'11"13'17
Granuloprival mice
It has been shown previously in both homogenate and autoradiographic studies that [3H]glutamate binding increases following neonatal MAM treatment in mouse cerebella. 36, 43 We have also found that when Purkinje cells are deafferentated by granule cell damage in MAM-treated mice there is an increase in quisqualate-specific [3H]glutamate binding in areas of the molecular layer adjacent to the regions of greatest granule cell ablation. Although we cannot rule out that the increase in receptor density is merely an effect of an enriched concentration of Purkinje cell dendrites in a parallel fiber-deficient area, it is noteworthy that Slevin et al. found a 70% increase in the binding of [3H]glutamate (under non-selective binding conditions) even when accounting for changes in loss of cerebellar mass. 43'47 By utilizing the anatomical resolution possible with receptor autoradiography and ligands selective for glutamate receptor subtypes we found the increase in glutamate receptors to be localized to the molecular layer of cerebellum and to be of the quisqualate type. Due to the deficiency of granule cell glutamatergic input and the preservation of normal postsynaptic dendritic spines on the Purkinje cells of granuloprival mice, it may be postulated that the increase in quisqualate receptor-specific ligand binding reflects an actual up-regulation of receptors on the surviving neurons. The up-regulation hypothesis seems likely to be due to the specificity of the binding sites being increased. 36 While the trend for the quisqualate receptorspecific ligands in the granuloprival mouse cerebellum is consistent, considerable variation in the degree of increased binding exists. There are both methodological and physiological explanations which could explain this difference. Methodologically, the data on the granuloprival cerebellum were obtained at single ligand concentrations and thus do not differentiate a relative change in receptor number or affinity. However, both Olson et al. 36 and Slevin et al. 43 have reported saturation studies in MAM-treated mouse cerebella that suggest only a change in receptor number and not in the affinity of glutamate binding sites. More likely, the discrepancy reflects the complexity of quisqualate receptors themselves. Not only is it possible that two classes of quisqualate receptors exist (ionotropic and metabotropic), it has been proposed that the ionotropic quisqualate receptor itself has dual affinity statesJ 9 We have provided evidence that three receptor ligands can be used to label quisqualate-specific EAA binding sites: quisqualate-sensitive [3H]glutamate binding, [3H]AMPA binding, and [3H]CNQX binding. Although the changes observed with the different ligands were not identical, the direction of the changes correlated well in the Purkinje cell-deficient ("nervous" mutants) and granuloprival (MAMtreated) mouse cerebella studied here. Thus, we have provided new and corroborative evidence that suggests that qulsqualate receptors, measured with three different ligands, localize to the dendrites of cerebellar Purkinje cells and can up-regulate in response to deafferentation. Also, we have demonstrated that both NMDA and glycine receptor populations are located predominantly in the granule cell layer and that they are probably not present on Purkinje cells in the molecular layer in adult mice. Finally, the present data suggest that the low affinity AMPA binding site may be the component of AMPA binding which corresponds to the physiologically relevant receptor.
